Integral Diagnostics Ltd

IDX: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|D&c&y>LOCK|XJLOCK|gLq?%q

Integral Diagnostics Earnings: Integration of Capitol Health Tracking Ahead

Integral Diagnostics’ fiscal 2025 EBITDA grew 38% on the successful integration of Capitol Health in December. EBITDA margin on a pro forma basis is up 150 basis points to 20%, and the firm increased annual cost-saving targets by another AUD 4 million. Shares reacted positively, up 11%.

Sponsor Center